News & Analysis as of

False Claims Act (FCA) › Biogen Idec

Sheppard Mullin Richter & Hampton LLP

Biogen Settlement Summary

Sheppard Mullin Richter & Hampton LLP on

On Monday September 26, the Department of Justice announced a settlement resolving a lawsuit filed by former employee Michael Bawduniak (the “Plaintiff”) against Biogen Inc. (the “Company”) under the qui tam provisions of the...more

Dorsey & Whitney LLP

A Hefty Speaking Fee: Biogen Inc. Agrees to Settle False Claims Act Suit In Violation of Anti-Kickback Statute for $900 Million

Dorsey & Whitney LLP on

​​​​​​​On July 20, 2022, Biogen Inc. (“Biogen”) disclosed in a quarterly earnings report that it had agreed to pay $900 million to resolve a qui tam claim by a former employee that the company had violated the False Claims...more

Patrick Malone & Associates P.C. | DC Injury...

Money’s big for Big Pharma — in settlements, lobbying, and product prices

Patrick Malone & Associates P.C. | DC Injury... on

Even as drug makers are settling or scrambling to resolve disputes with regulators over dubious ways they peddle products, Big Pharma is busting records for its spending to lobby lawmakers on skyrocketing prices, easing...more

3 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide